Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection.
Billiet C, Peeters S, Decaluwé H, Vansteenkiste J, Dooms C, Deroose CM, Hendrikx M, De Leyn P, Bulens P, Karim R, Le Péchoux C, Mebis J, De Ruysscher D. Billiet C, et al. Among authors: bulens p. J Thorac Oncol. 2016 Nov;11(11):1940-1953. doi: 10.1016/j.jtho.2016.06.018. Epub 2016 Jul 5. J Thorac Oncol. 2016. PMID: 27393474 Free article.
Assessing cancer patients' quality of life and supportive care needs: Translation-revalidation of the CARES in Flemish and exhaustive evaluation of concurrent validity.
Schouten B, Van Hoof E, Vankrunkelsven P, Schrooten W, Bulens P, Buntinx F, Mebis J, Vandijck D, Cleemput I, Hellings J. Schouten B, et al. Among authors: bulens p. BMC Health Serv Res. 2016 Mar 11;16:86. doi: 10.1186/s12913-016-1335-4. BMC Health Serv Res. 2016. PMID: 26969509 Free PMC article.
Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes.
Billiet C, De Ruysscher D, Peeters S, Decaluwé H, Vansteenkiste J, Dooms C, Deroose CM, De Leyn P, Hendrikx M, Bulens P, Le Péchoux C, Mebis J. Billiet C, et al. Among authors: bulens p. J Thorac Oncol. 2016 Sep;11(9):1538-49. doi: 10.1016/j.jtho.2016.05.037. Epub 2016 Jun 30. J Thorac Oncol. 2016. PMID: 27374454 Free article.
Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial).
Robijns J, Censabella S, Claes S, Pannekoeke L, Bussé L, Colson D, Kaminski I, Bulens P, Maes A, Noé L, Brosens M, Timmermans A, Lambrichts I, Somers V, Mebis J. Robijns J, et al. Among authors: bulens p. Lasers Surg Med. 2018 Feb 10. doi: 10.1002/lsm.22804. Online ahead of print. Lasers Surg Med. 2018. PMID: 29427390
Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J, Censabella S, Claes S, Pannekoeke L, Bussé L, Colson D, Kaminski I, Lodewijckx J, Bulens P, Maes A, Noé L, Brosens M, Timmermans A, Lambrichts I, Somers V, Mebis J. Robijns J, et al. Among authors: bulens p. Support Care Cancer. 2019 Apr;27(4):1245-1254. doi: 10.1007/s00520-018-4487-4. Epub 2018 Oct 1. Support Care Cancer. 2019. PMID: 30270415 Clinical Trial.
41 results